CVRdatabase
Menu

Vitrolife A/S

Public limited companyCVR 27406793Viby JActive

Vitrolife A/S is a public limited company, based in Viby J, active in manufacture of medical and dental instruments and supplies, founded in 2003. Net profit fell 15% from 2024 to 2025, ending at DKK 110.5m. Measured by gross profit, it ranks no. 7 of 185 companies in the industry in the database. With 116 employees, the company is about 29 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 228.4m−8.5% vs. 2024
Net profitDKK 110.5m−15.2% vs. 2024
EquityDKK 327.8m+3.5% vs. 2024
Employees116latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 9% (2024 → 2025), to DKK 228.4m.
  • Net profit fell 15% (2024 → 2025), to DKK 110.5m.
  • Equity rose 4% (2024 → 2025), to DKK 327.8m.

Employees

  • 5 fewer employees than a year earlier: 116 (08/2026) against 121 (08/2025).

Management and owners, last 24 months

  • New in management: Tom Faes (board member, 04/06/2025), Dag Erik Rickard Ericsson (board member, 24/10/2025) and Dag Erik Rickard Ericsson (ceo, 24/10/2025) (+2).
  • Stepped down: Claus Bisgaard (board member, 24/10/2025), Claus Bisgaard (ceo, 24/10/2025) and Bo Lars Risberg (board member, 04/06/2025) (+2).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 50mDKK 100mDKK 150mDKK 200mDKK 250mDKK 300mDKK 350m202020212022202320242025
EquityNet profit
Financial figures for Vitrolife A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit130,352194,179219,325216,829249,707228,406−8.5%
Operating profit (EBIT)73,018122,159139,068132,399162,666142,738−12.3%
Profit before tax73,086123,640137,963132,152166,691141,919−14.9%
Net profit57,31696,519107,758103,153130,285110,486−15.2%
Total assets266,724323,167295,855286,187377,793387,222+2.5%
Equity210,583247,479255,754239,414316,677327,840+3.5%
Liabilities50,18270,11435,45242,14654,84549,569−9.6%
Cash and cash equivalents9,86619,34314,43415,76846,15422,574−51.1%
Average number of employees828690100108116+7.4%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 50mDKK 100mDKK 150mDKK 200mDKK 250m202020212022202320242025
Gross profitMedian, the industry (185 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Vitrolife A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202515/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202403/06/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202326/06/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202220/06/2023The groupPDF not statedXBRL
202101/01/2021 – 31/12/202104/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202003/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02040608010012009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

185 companies in the database

Comparison with the other companies in manufacture of medical and dental instruments and supplies based on the latest financial year.

Gross profitDKK 228.4mNo. 7 of 185
Better than 97% of the companies in the industry
EquityDKK 327.8mNo. 6 of 185
Better than 97% of the companies in the industry
Number of employees116No. 13 of 185
Better than 93% of the companies in the industry

Industry median: gross profit DKK 2.5m, net profit DKK 224k, equity DKK 1.9m, 4 employees.

DKK 100kDKK 2.1mDKK 43.5mDKK 908.1mDKK 6.9bnHere
Distribution of gross profit for 170 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 145of 4,412
Better than 97%
No. 212of 4,466
Better than 95%
Same industry and 50–199 employees12 companies in the comparison
No. 2of 12
Better than 91%
No. 1of 12
Better than 100%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 282of 24,791
Better than 99%
No. 510of 24,909
Better than 98%
All companies of type A/S18,025 companies in the comparison
No. 678of 17,786
Better than 96%
No. 980of 18,024
Better than 95%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of medical and dental instruments and supplies
Gross profit
  1. Vitrolife A/SDKK 228.4m
  2. Coloplast A/SDKK 18.9bn
  3. Unomedical A/SDKK 1.2bn
Net profit
  1. Vitrolife A/SDKK 110.5m
  2. Coloplast A/SDKK 3.6bn
  3. Unomedical A/SDKK 731.7m
Equity
  1. Vitrolife A/SDKK 327.8m
  2. Coloplast A/SDKK 16.1bn
  3. Unomedical A/SDKK 2.2bn
Employees
  1. Vitrolife A/S116
  2. Coloplast A/S1,501
  3. Unomedical A/S606

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Vitrolife AB100%
Vitrolife A/S

Management

4 active registrations

Executive management

Executive management at Vitrolife A/S
NameRoleAppointed
Dag Erik Rickard EricssonCEO24/10/2025

Board of directors

Board of directors at Vitrolife A/S
NameRoleAppointed
Tom FaesBoard member04/06/2025
Dag Erik Rickard EricssonBoard member24/10/2025
Sten Jakob HedénChair of the board24/10/2025
Founders
Unisense Holding A/S
Former management (29)
Former management at Vitrolife A/S
NameRoleAppointedResigned
Jens Kristian Ellekilde GundersenDirector20/10/200314/06/2013
Carl Erik SkovgaardBoard member16/09/200509/07/2009
Per Christian GernowBoard member16/09/200509/02/2007
Sylvie Elisabeth BoveBoard member09/02/200730/05/2011
Jens BorumBoard member23/01/200918/05/2009
Peter Mørch EriksenBoard member26/04/201002/12/2010
Tom Henning RiisomChair of the board26/04/201030/05/2013
Jens Kristian Ellekilde GundersenBoard member02/12/201030/05/2011
Hans Jørgen Angaard MadsenBoard member30/05/201123/05/2012
Kirsten Marie JakobsenBoard member30/05/201123/11/2012
Manuel de la LlaveBoard member30/05/201123/11/2012
Lars Rabe TønnesenBoard member23/05/201226/11/2014
Søren NielsenBoard member23/11/201226/11/2014
Claus JørgensenBoard member01/03/201326/11/2014
Christian GrøndahlChair of the board30/05/201326/11/2014
Michael ReeslevCEO14/06/201304/12/2014
Hans Thomas AxelssonBoard member26/11/201430/05/2016
Per Stefan Harry PetterssonBoard member26/11/201431/05/2016
Erik Mikael EngblomBoard member26/11/201410/01/2022
Steffen Broe NielsenCEO04/12/201423/05/2019
Steffen Broe NielsenBoard member31/05/201623/05/2019
Hans Thomas AxelssonChair of the board31/05/201631/03/2023
Claus BisgaardDirector01/12/201722/05/2019
Claus BisgaardBoard member23/05/201924/10/2025
Claus BisgaardCEO23/05/201924/10/2025
Tony Patrik TolfBoard member10/01/202230/03/2023
Bo Lars RisbergBoard member10/01/202204/06/2025
Tony Patrik TolfChair of the board31/03/202321/02/2025
Dag Erik Rickard EricssonChair of the board21/02/202523/10/2025

Signing rule: Selskabet tegnes af et bestyrelsesmedlem eller af en direktør.

Address and production units

1 active production units

Jens Juuls Vej 16
8260 Viby J

Aarhus Municipality · Postcode 8260

Production units
Production unitAddressEmployeesP number
Vitrolife A/SJens Juuls Vej 16, 8260 Viby J1161027753031

Purpose

Selskabets formål er er at udvikle, demonstrere og kommercialisere udstyr til optimering af fertilitetsbehandling samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.

The purpose is quoted from the register in Danish.

Changes year by year

93 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
202511 changesmanagement 10 · accounts 1
  • Sten Jakob Hedén appointed chair of the board
  • Dag Erik Rickard Ericsson appointed ceo
  • Dag Erik Rickard Ericsson appointed board member
  • Claus Bisgaard stepped down as board member
  • Claus Bisgaard stepped down as ceo
  • Dag Erik Rickard Ericsson stepped down as chair of the board
  • Tom Faes appointed board member
  • Bo Lars Risberg stepped down as board member
  • Annual report for 2024 published
  • Dag Erik Rickard Ericsson appointed chair of the board
  • Tony Patrik Tolf stepped down as chair of the board
20242 changesaccounts 1 · address 1
  • Annual report for 2023 published
  • Moved to Jens Juuls Vej 16, 8260 Viby J
20234 changesaccounts 1 · management 3
  • Annual report for 2022 published
  • Tony Patrik Tolf appointed chair of the board
  • Hans Thomas Axelsson stepped down as chair of the board
  • Tony Patrik Tolf stepped down as board member
20224 changesaccounts 1 · management 3
  • Annual report for 2021 published
  • Bo Lars Risberg appointed board member
  • Tony Patrik Tolf appointed board member
  • Erik Mikael Engblom stepped down as board member
20212 changesindustry 1 · accounts 1
  • Industry changed to Manufacture of medical and dental instruments and supplies (325000)
  • Annual report for 2020 published
20195 changesmanagement 5
  • Claus Bisgaard appointed board member
  • Claus Bisgaard appointed ceo
  • Steffen Broe Nielsen stepped down as board member
  • Steffen Broe Nielsen stepped down as ceo
  • Claus Bisgaard stepped down as director
20171 changemanagement 1
  • Claus Bisgaard appointed director
20164 changesmanagement 4
  • Steffen Broe Nielsen appointed board member
  • Hans Thomas Axelsson appointed chair of the board
  • Per Stefan Harry Pettersson stepped down as board member
  • Hans Thomas Axelsson stepped down as board member
20151 changeaddress 1
  • Moved to Jens Juuls Vej 20, 8260 Viby J
201412 changesmanagement 9 · name 1 · ownership 1 · capital 1
  • Steffen Broe Nielsen appointed ceo
  • Michael Reeslev stepped down as ceo
  • Name changed from UNISENSE FERTILITECH A/S to VITROLIFE A/S
  • Hans Thomas Axelsson appointed board member
  • Per Stefan Harry Pettersson appointed board member
  • Erik Mikael Engblom appointed board member
  • Christian Grøndahl stepped down as chair of the board
  • Claus Jørgensen stepped down as board member
  • Søren Nielsen stepped down as board member
  • Lars Rabe Tønnesen stepped down as board member
  • Vitrolife AB registered as owner (100%)
  • Share capital changed from 3,664,250 DKK to 3,741,200 DKK
20139 changescapital 4 · management 5
  • Share capital changed from 3,661,300 DKK to 3,664,250 DKK
  • Michael Reeslev appointed ceo
  • Jens Kristian Ellekilde Gundersen stepped down as director
  • Christian Grøndahl appointed chair of the board
  • Tom Henning Riisom stepped down as chair of the board
  • Share capital changed from 3,661,270 DKK to 3,661,300 DKK
  • Share capital changed from 3,661,240 DKK to 3,661,270 DKK
  • Claus Jørgensen appointed board member
  • Share capital changed from 3,596,860 DKK to 3,661,240 DKK
20128 changescapital 3 · management 5
  • Share capital changed from 3,596,850 DKK to 3,596,860 DKK
  • Share capital changed from 3,342,020 DKK to 3,596,850 DKK
  • Søren Nielsen appointed board member
  • Manuel de la Llave stepped down as board member
  • Kirsten Marie Jakobsen stepped down as board member
  • Share capital changed from 3,273,350 DKK to 3,342,020 DKK
  • Lars Rabe Tønnesen appointed board member
  • Hans Jørgen Angaard Madsen stepped down as board member
20115 changesmanagement 5
  • Hans Jørgen Angaard Madsen appointed board member
  • Manuel de la Llave appointed board member
  • Kirsten Marie Jakobsen appointed board member
  • Jens Kristian Ellekilde Gundersen stepped down as board member
  • Sylvie Elisabeth Bove stepped down as board member
20107 changescapital 2 · management 4 · address 1
  • Share capital changed from 3,158,850 DKK to 3,273,350 DKK
  • Jens Kristian Ellekilde Gundersen appointed board member
  • Peter Mørch Eriksen stepped down as board member
  • Share capital changed from 2,985,110 DKK to 3,158,850 DKK
  • Tom Henning Riisom appointed chair of the board
  • Peter Mørch Eriksen appointed board member
  • Moved to Tueager 1, 8200 Aarhus N
20095 changescapital 2 · management 3
  • Share capital changed from 2,582,690 DKK to 2,985,110 DKK
  • Carl Erik Skovgaard stepped down as board member
  • Jens Borum stepped down as board member
  • Share capital changed from 1,987,630 DKK to 2,582,690 DKK
  • Jens Borum appointed board member
20081 changeindustry 1
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20073 changescapital 1 · management 2
  • Share capital changed from 1,194,230 DKK to 1,987,630 DKK
  • Sylvie Elisabeth Bove appointed board member
  • Per Christian Gernow stepped down as board member
20062 changescapital 1 · address 1
  • Share capital changed from 995,880 DKK to 1,194,230 DKK
  • Moved to Brendstrupgårdsvej 21F, 8200 Århus N
20054 changesname 1 · capital 1 · management 2
  • Name changed from UNISENSE FERTILITECH ApS to UNISENSE FERTILITECH A/S
  • Share capital changed from 125,000 DKK to 995,880 DKK
  • Per Christian Gernow appointed board member
  • Carl Erik Skovgaard appointed board member
20032 changesfounded 1 · management 1
  • Registered as UNISENSE FERTILITECH ApS
  • Jens Kristian Ellekilde Gundersen appointed director

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction